ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,410Medicare Part D Prescriptions Filled, Including Refills

Rank: 157 out of 5176

$1.26M Total Retail Price of All Prescriptions

Rank: 155 out of 5176

399 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 12,931 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,025 822 1 1
LISINOPRIL 795 547 2 5
AMLODIPINE BESYLATE 780 665 3 2
METFORMIN HCL 686 544 4 7
OMEPRAZOLE 582 460 5 3
ZOLPIDEM TARTRATE 579 357 6 17
HYDROCHLOROTHIAZIDE 507 401 7 10
LOSARTAN POTASSIUM 468 398 8 14
GLYBURIDE 404 319 R 9 67
ATORVASTATIN CALCIUM 339 274 10 9
FUROSEMIDE 336 293 11 8
DIOVAN 326 279 12 19
NEXIUM 321 228 13 16
ATENOLOL 290 227 14 12
METOPROLOL TARTRATE 279 253 15 6
LEVOTHYROXINE SODIUM 275 226 16 4
RANITIDINE HCL 271 210 17 36
VENTOLIN HFA 253 151 18 64
JANUVIA 223 170 19 25
GLIMEPIRIDE 218 198 20 37
CARVEDILOL 183 156 21 24
CLOPIDOGREL 182 141 22 26
OXYCODONE-ACETAMINOPHEN 175 96 S2 23 101
GABAPENTIN 174 111 24 21
CRESTOR 166 137 25 15
PLAVIX 156 131 26 29
ALENDRONATE SODIUM 154 134 27 18
METOPROLOL SUCCINATE 152 120 28 11
LOSARTAN-HYDROCHLOROTHIAZIDE 149 116 29 35
DONEPEZIL HCL 136 136 30 28
ACETAMINOPHEN-CODEINE 134 93 S3 31 127
IBUPROFEN 127 69 32 72
CLOBETASOL PROPIONATE 118 67 33 130
DIOVAN HCT 117 110 34 39
ATRIPLA 107 46 35 254
TAMSULOSIN HCL 104 94 36 20
LANTUS 101 84 37 66
SINGULAIR 100 65 38 62
PRAVASTATIN SODIUM 99 96 39 23
PAROXETINE HCL 99 79 39 93
PROAIR HFA 99 73 39 60
TRAMADOL HCL 96 53 42 40
SINGLE USE SWAB 93 65 43 108
AMMONIUM LACTATE 86 63 44 91
TRIAMCINOLONE ACETONIDE 84 42 45 125
ADVAIR DISKUS 84 48 45 32
GLIPIZIDE XL 82 69 47 83
NIFEDIPINE ER 80 35 48 48
AZITHROMYCIN 78 61 49 42
ENALAPRIL MALEATE 75 55 50 22
PATANOL 74 40 51 158
CLOTRIMAZOLE-BETAMETHASONE 73 35 52 94
OXYCODONE HCL-ACETAMINOPHEN 69 35 S2 53 258
ZETIA 69 69 53 68
WARFARIN SODIUM 67 43 55 13
FLUTICASONE PROPIONATE 66 52 56 38
GLIPIZIDE 66 52 56 63
MONTELUKAST SODIUM 66 43 56 123
CITALOPRAM HBR 65 37 59 31
ENDOCET 62 23 S2 60 246
ISOSORBIDE MONONITRATE ER 61 61 61 44
SPIRONOLACTONE 58 47 62 88
MELOXICAM 58 40 62 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 19 62 181
DIGOXIN 57 45 65 56
DILTIAZEM 24HR CD 55 45 66 119
DOXAZOSIN MESYLATE 53 53 67 103
ALLOPURINOL 52 35 68 41
LIPITOR 52 50 68 51
LANTUS SOLOSTAR 50 36 70 70
TRUVADA 50 21 70 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.